OXYGEN


Trade Names	OXYGEN, USP
Synonyms	Dioxygen E-948 E948 INS NO.948 INS-948 Molecular oxygen Oxygen Oxygen 93 percent Oxygen molecule Oxygenium RNS-60 COMPONENT OXYGEN RNS60 COMPONENT OXYGEN
Status
Molecule Category	UNKNOWN
ATC	V03AN01
UNII	S88TT14065
EPA CompTox	DTXSID2037681


Active Pharmaceutical Ingredients Bioactive chemicals	Exact Similarity SubStructure	Threshold (%) >= 70

Structure


InChI Key	MYMOFIZGZYHOMD-UHFFFAOYSA-N
Smiles	O=O
InChI	InChI=1S/O2/c1-2

Physicochemical Descriptors

Property Name	Value
Molecular Formula	O2
Molecular Weight	32.0
AlogP	0.07
Hydrogen Bond Acceptor	2.0
Hydrogen Bond Donor	0.0
Number of Rotational Bond	0.0
Polar Surface Area	34.14
Molecular species	None
Aromatic Rings	0.0
Heavy Atoms	2.0

Cross References

Resources	Reference
ChEBI	27140
ChEMBL	CHEMBL1234886
DrugBank	DB09140
DrugCentral	4235
FDA SRS	S88TT14065
Human Metabolome Database	HMDB0001377
KEGG	C00007
PDB	OXY
PubChem	977
SureChEMBL	SCHEMBL821

CONTENTS


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).